Biopolym. Cell. 2021; 37(2):125-142.
Bioorganic Chemistry
Design, synthesis and anticonvulsant activity of new Diacylthiosemicarbazides
1Kholodniak O. V., 1Stavytskyi V. V., 1Kazunin M. S., 1Bukhtiayrova N. V., 1Berest G. G., 1Belenichev I. F., 1Kovalenko S. I.
  1. Zaporizhia State Medical University
    26, Mayakovsky avenue, Zaporizhzhia, Ukraine, 69035


Aim. A targeted search for anticonvulsant agents among unknown diacylthiosemicarbazides with the analysis of the structure-activity relationship (SAR-analysis). Methods. Organic synthesis; molecular docking; spectral methods; pentylenetetrazole convulsions, statistical methods. Results. A strategy of search for new anticonvulsant agents among unknown diacylthiosemicarbazides has been developed. It included virtual-oriented screening towards [the] active centers of enzymes and sodium channels that underlie the mechanism of antiepileptic drugs activity. The synthesis of diacylthiosemicarbazides was carried out by the in situ method, namely, accomplishing the interaction of cycloalkanecarbonyl chlorides with ammonium isothiocyanate and the subsequent nucleophilic addition of cycloalkyl- (aralkyl-, aryl-, hetaryl-) carboxylic acid hydrazides. The peculiarities of the structure of the synthesized compounds were confirmed by spectral methods (LCMS and 1H NMR spectra). Biological screening showed that diacylthiosemicarbazides (2) in the experimental model of pentyleneterazole seizures in rats increased the latency period of seizures by 2.77–7.82 times, reduced the duration of tonic-clonic seizures by 1.23–5.59 minutes and prevented mortality by 30–60 %, relative to the control group of animals. It was shown that dia-cylthiosemicarbazides (2.6, 2.15, 2.22, 2.18) with cyclopropane- or cyclopentanecarboxamide groups show the anticonvulsant activity that exceeds that of the reference drug Depakine or competes with it. Conclusions. A range of new diacylthiosemicarbazides were obtained and the primary screening of their anticonvulsant activity was performed, the SAR-analysis was provided, and the hit-compound was identified for further in-depth pharmacological studies.
Keywords: diacylthiosemicarbazides, design, synthesis, pentylenetetrazole convulsions, anticonvulsant activity


[1] Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia. 2003;44 Suppl 4:21-9.
[2] Lundberg S, Eeg-Olofsson O. Rolandic epilepsy: a challenge in terminology and classification. Eur J Paediatr Neurol. 2003;7(5):239-41.
[3] Lima JM. The new drugs and the strategies to manage epilepsy. Curr Pharm Des. 2000;6(8):873-8.
[4] Bialer M, White HS. Key factors in the discovery and development of new antiepileptic drugs. Nat Rev Drug Discov. 2010;9(1):68-82.
[5] Al-Otaibi F. An overview of structurally diversified anticonvulsant agents. Acta Pharm. 2019;69(3):321-44.
[6] Lee H, Le HV, Wu R, Doud E, Sanishvili R, Kellie JF, Compton PD, Pachaiyappan B, Liu D, Kelleher NL, Silverman RB. Mechanism of Inactivation of GABA Aminotransferase by (E)- and (Z)-(1S,3S)-3-Amino-4-fluoromethylenyl-1-cyclopentanoic Acid. ACS Chem Biol. 2015;10(9):2087-98.
[7] Masereel B, Lambert DM, Dogné JM, Poupaert JH, Delarge J. Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas. Epilepsia. 1997;38(3):334-7.
[8] Pandeya SN, Mishra V, Singh PN, Rupainwar DC. Anticonvulsant activity of thioureido derivatives of acetophenone semicarbazone. Pharmacol Res. 1998;37(1):17-22.
[9] Pandeya SN, Mishra V, Ponnilavarasan I, Stables JP. Anticonvulsant activity of p-chlorophenyl substituted arylsemicarbazones--the role of primary terminal amino group. Pol J Pharmacol. 2000;52(4):283-90.
[10] Celen AO, Kaymakcioglu B, Gumru S, Toklu HZ, Aricioglu F. Synthesis and anticonvulsant activity of substituted thiourea derivatives. Marmara Pharm J. 2011; 15: 43–7.
[11] Kumar D, Sharma VK, Kumar R, Singh T, Singh H, Singh AD, Roy RK. Design, synthesis and anticonvulsant activity of some new 5,7-dibromoisatin semicarbazone derivatives. EXCLI J. 2013;12:628-40.
[12] Celen AO, Kaymakcioglu B, Gumru S, Toklu HZ, Aricioglu F. Synthesis and anticonvulsant activity of substituted thiourea derivatives. Marmara Pharm J. 2011; 15: 43–7.
[13] Aggarwal N, Mishra P. Synthesis of 4-aryl substituted semicarbazones of some terpenes as novel anticonvulsants. J Pharm Pharm Sci. 2004;7(2):260-4.
[14] Divar M, Yeganeh Y, Jamshidzadeh A, Heidari R, Khabnadideh S. Anticonvulsant activity of some semicarbazone and thiosemicarbazone derivatives of isatin on PTZ induced seizure. J Innov Appl Pharm Sci. 2017; 2(3): 4–14.
[15] Talele TT. The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. J Med Chem. 2016;59(19):8712-56.
[16] Agrawal S, Jain J, Kumar A, Gupta P, Garg V. Synthesis molecular modeling and anticonvulsant activity of some hydrazone, semicarbazone, and thiosemicarbazone derivatives of benzylidene camphor. Res Rep Med Chem. 2014; 4: 47–58.
[17] Gajbhiye A. Synthesis and anticonvulsant activity of some 1-cyclohexylidine/ cycloheptylidine-4-substitued semicarbazide derivatives. Int J Pharmacol Pharmaceut Tech. 2017; 1(2): 51–6.
[18] He X, Zhong M, Yang J, Wu Z, Xiao Y, Guo H, Hu X. Synthesis and anticonvulsant activity of 1-(2-(8-(benzyloxy)quinolin-2-yl)-1-butyrylcyclopropyl)-3-substituted urea derivatives. Chem Biol Drug Des. 2012;79(5):771-9.
[19] Carruthers W, Coldham I. ‘Modern Methods of Organic Synthesis 4th edition’. Cambridge: University Press, 2004; 493p.
[20] Kholodniak OV, Kazunin MS, Meyer F, Kovalenko SI, Steffens KG. Novel N-Cycloalkylcarbonyl-N'-arylthioureas: Synthesis, Design, Antifungal Activity and Gene Toxicity. Chem Biodivers. 2020;17(7):e2000212.
[21] Macdonald RL, Greenfield LJ Jr. Mechanisms of action of new antiepileptic drugs. Curr Opin Neurol. 1997;10(2):121-8.
[22] Hanaya R, Arita K. The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications. Neurol Med Chir (Tokyo). 2016;56(5):205-20.
[23] Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455-61.
[24] European convention for the protection of vertebrate animal used for experimental and other scientific purposes. Council of Europe: Strasbourg. 1986
[25] Golovenko MA, Gromov LO. Doklinichne vivchennya spetsifichnoyi aktivnosti potentsiinih protisudomnih preparativ. Kyiv: Metodichni rekomendatsiyi. DFC MOZ Ukrainy, 2003; 26 p.
[26] Lapach SN, Chubenko AV, Babich PN. Statisticheskie metodyi v mediko-biologicheskih issledovaniyah s ispolzovaniem EXCEL. Kyiv: Morion, 2001; 408 p
[27] Breitmaier E. Structure Elucidation by NMR in Organic Chemistry. Wiley: A Practical Guide/Eberhard Breitmaier. 3rd Revised Ed, 2002; 68p.